Insulin and IGF-I prevent brain atrophy and DNA loss in diabetes

被引:12
|
作者
Serbedzija, Predrag [2 ]
Madl, James E. [1 ]
Ishii, Douglas N. [1 ,2 ]
机构
[1] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA
[2] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA
关键词
Dementia; Insulin-like growth factor; Encephalopathy; Neurodegeneration; Brain edema; Diabetic neuropathy; GROWTH-FACTOR-I; HIPPOCAMPAL SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; CEREBRAL-ISCHEMIA; CEREBROSPINAL-FLUID; COGNITIVE FUNCTION; EVOKED-POTENTIALS; NEURITE FORMATION; CELL-DEATH; MELLITUS;
D O I
10.1016/j.brainres.2009.09.063
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The aim of this study was to identify factors that regulate the bulk of adult brain mass, and test the hypothesis that concomitantly reduced insulin and insulin-like growth factor (IGF) levels are pathogenic for brain atrophy associated with impaired learning and memory in diabetes. Doses of insulin, or insulin plus IGF-I that were too small to prevent hyperglycemia were infused for 12 weeks into the brain lateral ventricles of streptozotocin-diabetic adult rats. Brain wet, water and dry weights were significantly decreased in diabetic rats; insulin prevented these decreases. The decrease in brain DNA and protein contents in diabetic rats was prevented by the combination treatment, but not by insulin alone. Levels of several glia-and neuron-associated proteins were reduced in diabetes; these reductions were also prevented by the combination treatment. Although hyperglycemia was not prevented in plasma or cerebrospinal fluid, insulin prevented brain atrophy but not bulk DNA loss in diabetes, whereas the combination prevented both. Insulin actively prevented the loss of brain water content as well. Brain atrophy is associated with concomitantly reduced levels of insulin and IGF in other disorders such as Alzheimer's disease. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:179 / 194
页数:16
相关论文
共 50 条
  • [31] Insulin at physiological concentrations selectively activates insulin but not insulin-like growth factor I (IGF-I) or insulin/IGF-I hybrid receptors in endothelial cells
    Li, GL
    Barrett, EJ
    Wang, H
    Chai, WD
    Liu, ZQ
    ENDOCRINOLOGY, 2005, 146 (11) : 4690 - 4696
  • [32] Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin/IGF-I hybrid receptor overexpression: Evidence for a second mechanism of IGF-I signaling
    Pandini, G
    Vigneri, R
    Costantino, A
    Frasca, F
    Ippolito, A
    Fujita-Yamaguchi, Y
    Siddle, K
    Goldfine, ID
    Belfiore, A
    CLINICAL CANCER RESEARCH, 1999, 5 (07) : 1935 - 1944
  • [33] INHIBITION OF INSULIN AND IGF-I RECEPTOR SIGNALING
    Pollak, M.
    ANNALS OF ONCOLOGY, 2008, 19 : 34 - 34
  • [34] Partial IGF-I deficiency demonstrates the critical role of IGF-I in growth and brain development
    Netchine, Irene
    Azzi, Salah
    Houang, Muriel
    Seurin, Danielle
    Daubas, Claudine
    Ricort, Jean Marc
    Legay, Christine
    Perin, Laurence
    Heirich, Robert
    Godeau, Francois
    Le Bouc, Yves
    HORMONE RESEARCH, 2006, 65 : 29 - 29
  • [35] Insulin/IGF-I hybrid receptors play a major role in IGF-I signaling in thyroid cancer
    Belfiore, A
    Pandini, G
    Vella, V
    Squatrito, S
    Vigneri, R
    BIOCHIMIE, 1999, 81 (04) : 403 - 407
  • [36] Characterisation of receptors for IGF-I and insulin; evidence for hybrid insulin/IGF-I receptor in human coronary artery endothelial cells
    Chisalita, Simona I.
    Nitert, Marloes Dekker
    Arnqvist, Hans J.
    GROWTH HORMONE & IGF RESEARCH, 2006, 16 (04) : 258 - 266
  • [37] Effects of human insulin and insulin aspart preparations on levels of IGF-I, IGFBPs and IGF bioactivity in patients with type 1 diabetes
    Zhulin Ma
    Jens Sandahl Christiansen
    Torben Laursen
    Chunsen Wu
    Torsten Lauritzen
    Tina Parkner
    Jan Frystyk
    BMC Endocrine Disorders, 14
  • [38] Loss of insulin/IGF-I signaling in islet α-cells blunts the autonomic response to hypoglycemia
    Kulkarni, RN
    Yin, C
    Hu, J
    McGuinness, O
    Herrera, P
    Abmann, A
    Schultz, T
    DIABETES, 2005, 54 : A70 - A70
  • [39] Effects of human insulin and insulin aspart preparations on levels of IGF-I, IGFBPs and IGF bioactivity in patients with type 1 diabetes
    Ma, Zhulin
    Christiansen, Jens Sandahl
    Laursen, Torben
    Wu, Chunsen
    Lauritzen, Torsten
    Parkner, Tina
    Frystyk, Jan
    BMC ENDOCRINE DISORDERS, 2014, 14
  • [40] Inactivation of muscle insulin and IGF-I receptors and insulin responsiveness
    Le Roith, D
    Kim, H
    Fernandez, AM
    Accili, D
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2002, 5 (04): : 371 - 375